Intracranial efficacy of sotorasib versus docetaxel in pretreated KRAS G12C-mutated advanced non-small cell lung cancer (NSCLC): Practice-informing data from a global, phase 3, randomized, controlled trial (RCT)
Dingemans, A. M. C. Syrigos, K. Livi, L. Paulus, A. Kim, S. W. Chen, Y. B. Felip, E. Griesinger, F. Ohashi, K. Zalcman, G.
Dingemans, A. M. C.
Syrigos, K.
Livi, L.
Paulus, A.
Kim, S. W.
Chen, Y. B.
Felip, E.
Griesinger, F.
Ohashi, K.
Zalcman, G.
Citations
Altmetric:
Abstract
Description
Date
2023
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Dingemans AMC, Syrigos K, Livi L, Paulus A, Kim SW, Chen YB, et al. Intracranial efficacy of sotorasib versus docetaxel in pretreated KRAS G12C-mutated advanced non-small cell lung cancer (NSCLC): Practice-informing data from a global, phase 3, randomized, controlled trial (RCT). Journal of Clinical Oncology. 2023 Jun;41(17). PubMed PMID: WOS:001043181100039.